We are live on ! Find out more
AVNS icon

Avanos Medical
AVNS

257 hedge funds and large institutions have $631M invested in Avanos Medical in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 71 increasing their positions, 72 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $510M → $631M (+$121M)

1% less repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 72

1.1% less ownership

Funds ownership: 97.78% → 96.68% (-1.1%)

6% less funds holding

Funds holding: 274 → 257 (-17)

29% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 42

Holders
257
Holders Change
-17
Holders Change %
-6.2%
% of All Funds
3.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
71
Reduced
72
Closed
42
Calls
$217K
Puts
–
Net Calls
+$217K
Net Calls Change
+$158K

Top Buyers

1
BCM
Boone Capital Management
Georgia
+$16M
2
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
+$13.1M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$11.6M
4
RA
Royce & Associates
New York
+$6.1M
5
Brown Advisory
Brown Advisory
Maryland
+$3.98M

Top Sellers

1
AC
Armistice Capital
New York
-$16.2M
2
Millennium Management
Millennium Management
New York
-$9.67M
3
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$7.72M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$7.26M
5
UBS Group
UBS Group
Switzerland
-$3.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
DTL
276
Dynamic Technology Lab
Singapore
– -$280K -24,916 Closed
Verition Fund Management
277
Verition Fund Management
Connecticut
– -$198K -17,600 Closed
CSP
278
Cary Street Partners
Virginia
– -$188K -16,750 Closed
VI
279
Versor Investments
New York
– -$186K -16,600 Closed
AGM
280
Alpine Global Management
New York
– -$177K -15,773 Closed
QC
281
Quadrature Capital
United Kingdom
– -$161K -14,296 Closed
AIM
282
Aigen Investment Management
New York
– -$145K -12,902 Closed
SSA
283
Schonfeld Strategic Advisors
New York
– -$122K -10,824 Closed
Envestnet Asset Management
284
Envestnet Asset Management
Illinois
– -$121K -10,746 Closed
HPC
285
HM Payson & Co
Maine
– -$14K -1,250 Closed
MSFP
286
Mark Sheptoff Financial Planning
Connecticut
– -$7.86K -700 Closed
Los Angeles Capital Management
287
Los Angeles Capital Management
California
– -$3.31K -297 Closed
CSPIA
288
Cary Street Partners Investment Advisory
Virginia
– -$2.92K -260 Closed
AAM
289
Advisors Asset Management
Colorado
– -$1.7K -151 Closed
EWA
290
EQ Wealth Advisors
Texas
– -$1.12K -100 Closed
PSB
291
Piscataqua Savings Bank
New Hampshire
– -$449 -40 Closed
JWM
292
Jessup Wealth Management
Ohio
– -$303 -27 Closed
SAM
293
Smartleaf Asset Management
Massachusetts
– -$136 -12 Closed
CA
294
Clearstead Advisors
Ohio
– -$113 -10 Closed
TF
295
Tompkins Financial
New York
– -$22 -2 Closed
8 9 10 11
12

AVNS Hedge Fund Activity: Q1 2026 in Review

257 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2026, worth a combined $631M — up 24% from $510M a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of AVNS and 30 opened new positions — a net loss of 12 holders — while 72 trimmed existing stakes and 71 added.

The largest buyer was Boone Capital Management, opening a new position worth an estimated $16M. The largest seller was Armistice Capital, cutting an estimated $16.2M.

  • 257 institutional investors held Avanos Medical (AVNS) as of Q1 2026, down from 274 in Q4 2025.
  • Funds reported $631M of Avanos Medical stock for Q1 2026, up 24% quarter-over-quarter.
  • 30 funds opened new Avanos Medical positions in Q1 2026 and 42 closed out, a net change of -12 holders.
  • The largest Avanos Medical buyer in Q1 2026 was Boone Capital Management, an estimated $16M added.
  • The largest Avanos Medical seller in Q1 2026 was Armistice Capital, an estimated $16.2M sold.

Based on aggregated 13F filings for Q1 2026.